Device
WARD
WARD is a medical device with 3 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
1(33%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
2
67%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
3
all time
Status Distribution
Active(1)
Completed(2)
Detailed Status
Completed2
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
1
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A2 (100.0%)
Trials by Status
completed267%
recruiting133%
Recent Activity
1 active trials
Showing 3 of 3
recruitingnot_applicable
Early Detection of Complications During Immunotherapy for Haematological Malignancy
NCT06377059
completednot_applicable
Comparing the Intravenous Treatment of Skin Infections in Children, Home Versus Hospital
NCT02334124
completed
Using Technical Filtering and Clinical Criteria to Reduce Vital Sign Alarms Using Continuous Monitoring in the Ward
NCT05171322
Clinical Trials (3)
Showing 3 of 3 trials
NCT06377059Not Applicable
Early Detection of Complications During Immunotherapy for Haematological Malignancy
NCT02334124Not Applicable
Comparing the Intravenous Treatment of Skin Infections in Children, Home Versus Hospital
NCT05171322
Using Technical Filtering and Clinical Criteria to Reduce Vital Sign Alarms Using Continuous Monitoring in the Ward
All 3 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 3